Catheter treatment for severe pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your pulmonary embolism was confirmed by a CT scan or a heart ultrasound and a lung artery X-ray.
- You have a high-risk or intermediate-high risk pulmonary embolism (based on blood tests and heart imaging).
- Your doctor thinks you may benefit from a catheter-based treatment (a thin tube placed in your vein to break up the clot).
- Your symptoms started within the last 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a catheter (a thin tube) to remove blood clots from the lungs early can help people with a severe, life-threatening pulmonary embolism. It is for patients who are in shock or have had a cardiac arrest due to a large clot.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.